99 related articles for article (PubMed ID: 23280017)
21. [Expression and significance of Fas and FasL protein in squamous cell carcinoma of larynx].
Shi L; Li G; Zhu C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):661-2. PubMed ID: 12669436
[TBL] [Abstract][Full Text] [Related]
22. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
[TBL] [Abstract][Full Text] [Related]
23. Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis.
Lu H; Gan M; Zhang G; Zhou T; Yan M; Wang S
Eur J Gynaecol Oncol; 2010; 31(6):662-6. PubMed ID: 21319512
[TBL] [Abstract][Full Text] [Related]
24. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
[TBL] [Abstract][Full Text] [Related]
25. Fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy.
Sejima T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Urol Int; 2012; 88(3):263-70. PubMed ID: 22398398
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
[TBL] [Abstract][Full Text] [Related]
27. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
28. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
29. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
30. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix.
Kim HS; Shiraki K; Park SH
Anticancer Res; 2002; 22(2A):805-8. PubMed ID: 12014654
[TBL] [Abstract][Full Text] [Related]
31. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Kai1 and FasL in non-small cell lung cancer and its clinicopathological significance].
Li Y; Wu D; Zheng H; Xin Y
Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):518-22. PubMed ID: 21208540
[TBL] [Abstract][Full Text] [Related]
33. MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis.
Cao XQ; Lu HS; Zhang L; Chen LL; Gan MF
Asian Pac J Cancer Prev; 2014; 15(13):5271-6. PubMed ID: 25040987
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E
Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913
[TBL] [Abstract][Full Text] [Related]
35. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
[TBL] [Abstract][Full Text] [Related]
36. Study on the correlation between the expression of Ki67 and FasL and prognosis of cervical carcinoma.
Liang SN; Huang YJ; Liu LL; Liu X
Genet Mol Res; 2015 Jul; 14(3):8634-9. PubMed ID: 26345794
[TBL] [Abstract][Full Text] [Related]
37. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
38. The TLR3, PI3K, survivin, FasL, and Fas genes as major risk factors of occurrence and development of cervical cancer disease.
Liu HN; Shi HR; Zhao XL; Zhang RT; Liu GZ; Zhang JX
Gene; 2014 Oct; 550(1):27-32. PubMed ID: 25106857
[TBL] [Abstract][Full Text] [Related]
39. Expression of survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the uterine cervix.
Sukpan K; Settakorn J; Khunamornpong S; Cheewakriangkrai C; Srisomboon J; Siriaunkgul S
Int J Gynecol Cancer; 2011 Jul; 21(5):911-7. PubMed ID: 21633298
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of RAGE and its ligand (S100A9) in cervical lesions.
Zhu X; Jin L; Zou S; Shen Q; Jiang W; Lin W; Zhu X
Cell Biochem Biophys; 2013 Jul; 66(3):843-50. PubMed ID: 23340902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
